Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $16.80 price target on the stock.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report